Benztropine 1 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are a prescription medicine used as an add-on treatment for all forms of parkinsonism. They are also used to help control extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

Each tablet contains benztropine mesylate 0.5 mg, 1 mg, or 2 mg for oral use. The inactive ingredients include corn starch, dicalcium phosphate anhydrous, hydrogenated vegetable oil, lactose anhydrous, lactose monohydrate, microcrystalline cellulose, and talc.

The label says benztropine mesylate has anticholinergic effects and can cause side effects such as dry mouth, blurred vision, constipation, urinary retention, confusion, and drowsiness or weakness in some patients. It also warns that the medicine may affect mental and physical abilities needed for tasks like driving or operating machinery.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine only as directed by a healthcare professional.
• The tablets are for oral use.
• The label says the dose should be started low and increased gradually when needed.
• This medicine may impair mental and/or physical abilities needed for driving or using machinery.
• Report gastrointestinal complaints, fever, or heat intolerance promptly if taking it with phenothiazines, haloperidol, or other anticholinergic or antidopaminergic drugs.
• Be aware that dry mouth, constipation, blurred vision, urinary retention, and confusion have been reported.
• Tell a healthcare professional if severe dry mouth makes it hard to swallow or speak.
• Use caution about heat exposure, since decreased sweating and hyperthermia have been reported.
• The label says to keep out of reach of children.
• Report side effects to the FDA or to Leading Pharma, LLC using the numbers listed on the label.

Helpful Patient Education

Benztropine Mesylate Tablets, USP are oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. According to the DailyMed label, this medicine is used as an adjunct in the therapy of all forms of parkinsonism and may also be used to help control extrapyramidal disorders caused by certain neuroleptic drugs, except tardive dyskinesia.

This product information reflects labeled use, warnings, precautions, and adverse reactions for benztropine mesylate tablets. Commonly listed anticholinergic-type effects include dry mouth, blurred vision, constipation, urinary retention, confusion, and heat-related problems, so the label advises careful supervision during treatment.

Medication Summary last generated: 2026-07-10 02:58:16